Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

Share Price Information for Braveheart Investments (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.25
Bid: 4.50
Ask: 6.00
Change: 0.25 (5.00%)
Spread: 1.50 (33.333%)
Open: 5.00
High: 5.25
Low: 5.00
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of Viking Fund Managers Limited

16 Apr 2019 07:00

RNS Number : 2638W
Braveheart Investment Group plc
16 April 2019
 

Prior to publication, certain information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.

 

16 April 2019

 

 

Braveheart Investment Group plc

("Braveheart" or the "Company")

 

Disposal of Viking Fund Managers Limited

 

 

Braveheart Investment Group plc (AIM: BRH) ("Braveheart"), the fund management and strategic investor group, is pleased to announce that, further to the announcement on 13 December 2018, completion has now been achieved on the sale of the entire issued ordinary share capital of its subsidiary company, Viking Fund Managers Limited ("Viking"). The consideration paid consists of a payment of £110,000 in cash, and an additional payment, estimated to be approximately £170,500, due to be paid in cash once the performance fee of an existing fund management contract has been agreed with the client in early 2020 ("Performance Fee"). Furthermore, cash held by Viking at the date of completion, which totalled £72,000, was not included in the sale and has now been transferred to Braveheart and the intercompany loans payable by Braveheart, Strathtay Ventures Limited (another subsidiary of Braveheart)("Strathtay") and Ridings Early Growth Investment Company Limited (another subsidiary of Braveheart)("REGIC") to Viking, amounting to approximately £650,000, were forgiven immediately prior to completion of the sale.

Not included within the sale are Ridings Holdings Limited ("RHL") and it's wholly owned subsidiary REGIC. The entire issued share capital of RHL was transferred to Braveheart before the date of completion.

In the year ended 31 March 2018, Viking achieved a profit before tax of £404,388 on revenues of £715,523. However, due to the declining fees that are being generated from existing contracts, the unaudited revenue of Viking for the year ended 31 March 2019 is estimated to be approximately £478,000 and the unaudited profit for the same period is estimated to be approximately £75,000. If no new contracts were entered into by Viking, the revenues for the year ending 31 March 2020 are expected to be significantly lower as the management contract for the Finance Yorkshire Equity Fund expires on 31 December 2019, as has been previously disclosed. As at 31 March 2018, Viking had audited net assets of £794,474, including intercompany loan balances of £457,171 due from Braveheart, Strathtay and REGIC, investments in RHL and REGIC of £45,000, an accrual for the Performance Fee of £174,939 and cash of £42,541. None of these assets are included as part of the sale of Viking.

It is proposed to use the sale proceeds from the sale of Viking for working capital purposes generally.

Despite the disposal of Viking, the Directors confirm that they intend to actively continue to run the fund management business and will continue to tender for opportunities as and when they arise.

Related Party Transaction

The purchasers of Viking are Jonathan Freeman, Ian Brown and James Bromhead. Jonathan Freeman is a Non-Executive Director of Braveheart and a director of Viking and, therefore, the transaction is treated as a related party transaction under the AIM Rules. Ian Brown is currently a consultant to Viking.

The independent Directors, Trevor Brown and Viv Hallam, consider, having consulted with Allenby Capital Limited, the Company's Nominated Adviser, that the terms of the sale of the entire ordinary share capital of Viking are fair and reasonable insofar as the shareholders of Braveheart are concerned.

For further information:

 

Braveheart Investment Group plcViv Hallam, Executive Director

 

 

Tel: 01738 587555

Allenby Capital Limited (Nominated Adviser and Joint Broker) David Worlidge / Nicholas Chambers

 

Tel: 020 3328 5656

 

 

Peterhouse Capital Limited (Joint Broker) Heena Karani / Lucy Williams

 

 

Tel: 020 7469 0936

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISIAMFTMBABBFL
Date   Source Headline
4th Dec 20147:00 amRNSLondon Co-investment Fund partnership
24th Nov 20147:00 amRNSCrowdcube Fund makes first four investments
23rd Sep 20147:00 amRNSDirector/PDMR Shareholding
23rd Sep 20147:00 amRNSDirectorate Change
22nd Sep 20142:10 pmRNSResult of AGM
1st Sep 20147:00 amRNSNotice of AGM
29th Aug 20143:16 pmRNSTotal Voting Rights
27th Aug 20147:00 amRNSDirector/PDMR Shareholding
20th Aug 20147:00 amRNSDirector/PDMR Shareholding
20th Aug 20147:00 amRNSAward of options
19th Aug 20147:00 amRNSDirector/PDMR Shareholding
14th Aug 201412:04 pmRNSHolding(s) in Company
14th Aug 201412:04 pmRNSHolding(s) in Company
11th Aug 20147:00 amRNSIssue of Equity
22nd Jul 20143:52 pmRNSHolding(s) in Company
22nd Jul 20147:00 amRNSDirector/PDMR Shareholding
21st Jul 20147:00 amRNSPreliminary Results
3rd Apr 20143:18 pmRNSHolding(s) in Company
3rd Apr 20141:32 pmRNSHolding(s) in Company
3rd Apr 20141:30 pmRNSHolding(s) in Company
1st Apr 20147:00 amRNSTotal Voting Rights
28th Mar 201411:29 amRNSAward for WhiteRock Capital Partners
25th Mar 20147:00 amRNSIssue of Equity and Directorate Change
31st Jan 20142:58 pmRNSTotal Voting Rights
31st Jan 20147:00 amRNSHolding(s) in Company
31st Jan 20147:00 amRNSHolding(s) in Company
27th Jan 20147:00 amRNSPartnership to launch co-investment fund
14th Jan 20147:00 amRNSIssue of Equity
18th Dec 20137:00 amRNSHalf Yearly Report
13th Dec 201312:29 pmRNSDisposal
11th Dec 20137:00 amRNSFinance Yorkshire Update
6th Dec 20137:00 amRNSWhiteRock Capital Partners update
26th Sep 20132:55 pmRNSResult of AGM
16th Sep 20137:00 amRNSEnvestors funds growth at FX firm Ebury Partners
4th Sep 20137:00 amRNSNotice of AGM
3rd Sep 20137:00 amRNSFinal Results
14th Aug 20137:00 amRNSWhiteRock Capital Partners update
26th Jul 20137:00 amRNSFirst exit from fund
11th Jun 20137:00 amRNSEnvestors announces its North strategy
16th May 20137:00 amRNSBraveheart's Envestors funds payasUgym
2nd May 20137:00 amRNSBraveheart announces Envestors funding for Loco2
22nd Apr 20137:00 amRNSEnvestors leads ComparaFinanza fundraising
15th Apr 20137:00 amRNSWhiteRock Capital Partners wins key industry award
12th Apr 20137:00 amRNSReorganisation of Yorkshire businesses
2nd Apr 20133:31 pmRNSDirectorate Change - amended
2nd Apr 20137:00 amRNSDirectorate Change
19th Mar 20137:00 amRNSAdviser change of name
22nd Feb 20133:45 pmRNSUpdate on WhiteRock and Growth Loan Fund -Amend
22nd Feb 20133:02 pmRNSUpdate on WhiteRock and Growth Loan Fund
21st Feb 20137:00 amRNSEnvestors closes funding for Cipher Surgical

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.